Cancel

Best Practices in the Management of Tumor Lysis Syndrome Associated With Emerging Cancer Therapies

Explore best practices in the management of tumor lysis syndrome associated with emerging cancer therapies. This activity, presented by Matthew S. Davids, MD, MMSc, Director of Clinical Research at Dana-Farber Cancer Institute, and Amy Goodrich, RN, BSN, MSN, CRNP-AC, Nurse Practitioner at Johns Hopkins Kimmel Cancer Center, will review plans to optimize prevention, recognition, and treatment, as well as discuss emerging therapies and monitoring strategies for patient care. Start the activity ...
i3 Health

What Every Clinician Needs to Know About COVID-19 and Thrombosis

As the COVID-19 pandemic continues to wage on, are you prepared to prevent and treat your patients for COVID-19-related venous thromboembolism (VTE)? In this short vlog, learn how to develop appropriate regimens with antithrombotic therapy for this patient population and hear about the promising PREVENT-HD trial. Leading VTE expert, Dr. Gregory Piazza, outlines key real-world insights that you need to know about these patients and their risk for VTE.
ACHL

Expert Physicians Discuss Guideline Focused Care in Hereditary Angioedema

Target Audience This activity is designed to meet the educational needs of clinicians involved in the diagnosis and management of patients with hereditary angioedema (HAE). Program Overview: This activity will provide learners with an opportunity to hear expert physicians discuss recently updated guidelines for HAE. The experts will cover important considerations in prophylactic treatment for HAE-C1INH, diagnosis and treatment for HAE-normal-C1INH, and how to create individualized HAE pati...
US HAEA

Respiratory Syncytial Virus: Protecting Older Adults at Risk for Serious Complications

Target Audience This activity was developed for family practice physicians, primary care physicians, nurse practitioners, nurses and other healthcare professionals who care for older adults. Program Overview Each year, respiratory syncytial virus (RSV) infects up to 10% of older adults who live in congregate settings and predisposes to an increased risk for hospitalization and death, particularly in those with comorbid cardiopulmonary disease. Stefan Gravenstein, MD, MPH, compares the...
The Annenberg Center for Health Sciences at Eisenhower

CSU: An Older African American Adult Male With Widespread, Persistent Pruritus

Target Audience The target audience will be comprised of allergists, dermatologists, specialty nurse practitioners, specialty physician assistants, and managed care/pharmacy directors. Program Overview Chronic spontaneous urticaria (CSU) is a chronic immune-mediated condition characterized by sudden development of wheals and/or angioedema, as well as presenting with significant debilitation and considerable burden on patients’ quality of life. The diagnosis and management of CSU is comp...
Relias LLC

Answering the Call: Nurse-Led Strategies to Improve Compliance with Hemophilia Prophylaxis

Prophylactic management of hemophilia continues to be a challenge. The nurse-led activity discusses treatment strategies, safety and efficacy of current available products, and how to improve patient adherence. In this clinical commentary Kerry H. Hansen, RN, BS and Skye Peltier, MPH, PA-C review best practices to facilitate successful therapeutic interventions with hemophilia A Kerry H. Hansen, RN, BS and Skye Peltier, MPH, PA-C
ACHL

Answering the Call: Nurse-Led Strategies to Improve Compliance with Hemophilia Prophylaxis

Target Audience This educational activity is designed for advanced practice nurses (APRN) including nurses and nurse practitioners (NP), physicians, and other clinicians in a hematology setting treating patients with hemophilia A Program Overview Prophylactic management of hemophilia continues to be a challenge. The nurse-led activity discusses treatment strategies, safety and efficacy of current available products, and how to improve patient adherence. In this clinical commentary, expert...
Relias LLC

Medical Crossfire®: Personalized Regimens for Managing Hemophilia A: Selecting an Optimal Recombinant FVIII Agent

Target Audience This online educational activity is directed toward hematologists, primary care clinicians, nurse practitioners, physician assistants, nurses, and other health care professionals who are involved in the management of hemophilia. Activity Overview Over the past 20 years, substantial advances in the treatment of hemophilia A have allowed patients to take greater control of their disease. The primary goals of hemophilia A treatment are to prevent bleeding episodes, reduce lon...
Relias LLC

Evaluating Emerging Gene Therapies to Further Treatment for Patients with Hemophilia A

Target Audience This initiative is intended for hemophilia specialists, hematologists, emergency department clinicians, nurses, medical geneticists, genetic counselors, and other healthcare providers who care for patients with hemophilia A. Program Overview Hemophilia A is an inherited bleeding disorders due to the partial or total deficiency of coagulation factor (F) VIII. Progress in hemophilia therapy has been remarkable over the last decades with the development of efficacious the...
AKH Inc., Advancing Knowledge in Healthcare and Catalyst Medical Education, LLC.

Clinical Complications, Challenges, and Comorbidities Assoicated with Hemophilia A and its Treatment

Target Audience This initiative is intended for hemophilia specialists, hematologists, emergency department clinicians, nurses, medical geneticists, genetic counselors, and other healthcare providers who care for patients with hemophilia A. Program Overview Hemophilia A is an inherited bleeding disorders due to the partial or total deficiency of coagulation factor (F) VIII. Progress in hemophilia therapy has been remarkable over the last decades with the development of efficacious the...
Sanofi Genzyme and Takeda Pharmaceuticals U.S.A., Inc.

Selecting and Dosing Clotting Factors to Individualize Treatment for Patients with Hemophilia A

Target Audience This initiative is intended for hemophilia specialists, hematologists, emergency department clinicians, nurses, medical geneticists, genetic counselors, and other healthcare providers who care for patients with hemophilia A. Program Overview Hemophilia A is an inherited bleeding disorders due to the partial or total deficiency of coagulation factor (F) VIII. Progress in hemophilia therapy has been remarkable over the last decades with the development of efficacious the...
AKH Inc., Advancing Knowledge in Healthcare and Catalyst Medical Education, LLC.

Expanding Patient Engagement to Advance Hemophilia A Treatment Adherence and Outcomes

Target Audience This initiative is intended for hemophilia specialists, hematologists, emergency department clinicians, nurses, medical geneticists, genetic counselors, and other healthcare providers who care for patients with hemophilia A. Program Overview Hemophilia A is an inherited bleeding disorders due to the partial or total deficiency of coagulation factor (F) VIII. Progress in hemophilia therapy has been remarkable over the last decades with the development of efficacious the...
AKH Inc., Advancing Knowledge in Healthcare and Catalyst Medical Education, LLC.

Community Practice Connections™: Venous Thromboembolism: Patient-Centric and Guideline-Directed Strategies for Optimal Coordinated Care

Target Audience The target audience for this activity is internists and internal medicine subspecialists. Other primary care providers, nurse practitioners, physician assistants, nurses, and other health care professionals involved in VTE management are invited to participate as well. Program Overview Venous thromboembolism (VTE) is a serious and underdiagnosed medical condition that manifests as deep vein thrombosis (DVT) and/or pulmonary embolism (PE) and can cause serious illness, ...
Physicians’ Education Resource®, LLC.

Best Practices in Nursing Management of Chemotherapy-Induced Peripheral Neuropathy

CIPN is a complication of cancer treatment that may lead to permanent nerve damage in severe cases. This online activity reviews causative agents, signs and symptoms, and supportive care interventions. 1.0 NCPD | ILNA STATEMENT OF NEED Chemotherapy-induced peripheral neuropathy (CIPN) is a complication of cancer treatment that may impair quality of life and lead to treatment dose reductions or discontinuation in severe cases. In one study of 123 patients receiving taxane therapy for bre...
i3 Health

APhA Pharmacists Association's Pharmacy-Based Travel Health Services

APhA’s Pharmacy-Based Travel Health Services (2nd Edition) is an innovative and interactive advanced competency training (ACT) program that explores the pharmacist’s role in providing travel health services to patients. This application-based activity is the first step for pharmacists interested in learning the essential skills necessary to successfully provide travel health services. Program pre-requisite: Pharmacists who have completed the APhA Pharmacy-Based Immunization Delivery certi...
Western University of Health Sciences, College of Pharmacy

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map